-
1
-
-
77951826915
-
The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults
-
Abel B, et al. 2010. The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. Am. J. Respir. Crit. Care Med. 181:1407-1417.
-
(2010)
Am. J. Respir. Crit. Care Med.
, vol.181
, pp. 1407-1417
-
-
Abel, B.1
-
2
-
-
22944433876
-
The success and failure of BCG - Implications for a novel tuberculosis vaccine
-
DOI 10.1038/nrmicro1211
-
Andersen P, Doherty TM. 2005. The success and failure of BCG-implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 3:656-662. (Pubitemid 41052152)
-
(2005)
Nature Reviews Microbiology
, vol.3
, Issue.8
, pp. 656-662
-
-
Andersen, P.1
Doherty, T.M.2
-
3
-
-
56649111225
-
Protein engineering towards biotechnological production of bifunctional polyester beads
-
Atwood JA, Rehm BHA. 2009. Protein engineering towards biotechnological production of bifunctional polyester beads. Biotechnol. Lett. 31:131-137.
-
(2009)
Biotechnol. Lett.
, vol.31
, pp. 131-137
-
-
Atwood, J.A.1
Rehm, B.H.A.2
-
4
-
-
33846807429
-
Recombinant Escherichia coli produces tailor-made biopolyester granules for applications in fluorescence activated cell sorting: Functional display of the mouse interleukin-2 and myelin oligodendrocyte glycoprotein
-
Bäckström BT, Brockelbank JA, Rehm BHA. 2007. Recombinant Escherichia coli produces tailor-made biopolyester granules for applications in fluorescence activated cell sorting: functional display of the mouse interleukin-2 and myelin oligodendrocyte glycoprotein. BMC Biotechnol. 7:3.
-
(2007)
BMC Biotechnol.
, vol.7
, pp. 3
-
-
Bäckström, B.T.1
Brockelbank, J.A.2
Rehm, B.H.A.3
-
5
-
-
79551718164
-
Lactococcus lactis-based vaccines: Current status and future perspectives
-
Bahey-El-Din M, Gahan CGM. 2011. Lactococcus lactis-based vaccines: current status and future perspectives. Hum. Vaccin. 7:106-109.
-
(2011)
Hum. Vaccin.
, vol.7
, pp. 106-109
-
-
Bahey-El-Din, M.1
Gahan, C.G.M.2
-
6
-
-
77950845407
-
Lactococcus lactis as a cell factory for delivery of therapeutic proteins
-
Bahey-El-Din M, Gahan CGM, Griffin BT. 2010. Lactococcus lactis as a cell factory for delivery of therapeutic proteins. Curr. Gene Ther. 10:34-45.
-
(2010)
Curr. Gene Ther.
, vol.10
, pp. 34-45
-
-
Bahey-El-Din, M.1
Gahan, C.G.M.2
Griffin, B.T.3
-
7
-
-
0031007903
-
Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis
-
DOI 10.1126/science.276.5317.1420
-
Belisle JT, et al. 1997. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276:1420-1422. (Pubitemid 27235411)
-
(1997)
Science
, vol.276
, Issue.5317
, pp. 1420-1422
-
-
Belisle, J.T.1
Vissa, V.D.2
Sievert, T.3
Takayama, K.4
Brennan, P.J.5
Besra, G.S.6
-
8
-
-
77955331504
-
First-in-man open clinical trial of a combined rdESAT-6 and rCFP-10 tuberculosis specific skin test reagent
-
Bergstedt W, et al. 2010. First-in-man open clinical trial of a combined rdESAT-6 and rCFP-10 tuberculosis specific skin test reagent. PLoS One 5:e11277.
-
(2010)
PLoS One
, vol.5
-
-
Bergstedt, W.1
-
9
-
-
55249098468
-
Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen
-
Borges O, et al. 2008. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen. Int. Immunopharmacol. 8:1773-1780.
-
(2008)
Int. Immunopharmacol.
, vol.8
, pp. 1773-1780
-
-
Borges, O.1
-
10
-
-
0023749235
-
Pseudomonas oleovorans as a source of poly(beta-hydroxyalkanoates) for potential applications as biodegradable polyesters
-
Brandl H, Gross RA, Lenz RW, Fuller RC. 1988. Pseudomonas oleovorans as a source of poly(beta-hydroxyalkanoates) for potential applications as biodegradable polyesters. Appl. Environ. Microbiol. 54:1977-1982.
-
(1988)
Appl. Environ. Microbiol.
, vol.54
, pp. 1977-1982
-
-
Brandl, H.1
Gross, R.A.2
Lenz, R.W.3
Fuller, R.C.4
-
11
-
-
0033979229
-
ESAT-6 subunit vaccination against Mycobacterium tuberculosis
-
DOI 10.1128/IAI.68.2.791-795.2000
-
Brandt L, Elhay M, Rosenkrands I, Lindblad EB, Andersen P. 2000. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect. Immun. 68:791-795. (Pubitemid 30056537)
-
(2000)
Infection and Immunity
, vol.68
, Issue.2
, pp. 791-795
-
-
Brandt, L.1
Elhay, M.2
Rosenkrands, I.3
Lindblad, E.B.4
Andersen, P.5
-
12
-
-
77957954442
-
Tuberculosis vaccines for cattle: The way forward
-
Buddle BM. 2010. Tuberculosis vaccines for cattle: the way forward. Expert Rev. Vaccines 9:1121-1124.
-
(2010)
Expert Rev. Vaccines
, vol.9
, pp. 1121-1124
-
-
Buddle, B.M.1
-
13
-
-
77952841173
-
Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved
-
Comas I, et al. 2010. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat. Genet. 42:498-503.
-
(2010)
Nat. Genet.
, vol.42
, pp. 498-503
-
-
Comas, I.1
-
14
-
-
0031822532
-
Zoonotic tuberculosis due to Mycobacterium bovis in developing countries
-
Cosivi O, et al. 1998. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg. Infect. Dis. 4:59-70. (Pubitemid 28347416)
-
(1998)
Emerging Infectious Diseases
, vol.4
, Issue.1
, pp. 59-70
-
-
Cosivi, O.1
Grange, J.M.2
Daborn, C.J.3
Raviglione, M.C.4
Fujikura, T.5
Cousins, D.6
Robinson, R.A.7
Huchzermeyer, H.F.A.K.8
De Kantor, I.9
Meslin, F.-X.10
-
15
-
-
77956312281
-
Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis
-
Deng YH, Sun Z, Yang XL, Bao L. 2010. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis. Scand. J. Immunol. 72:332-338.
-
(2010)
Scand. J. Immunol.
, vol.72
, pp. 332-338
-
-
Deng, Y.H.1
Sun, Z.2
Yang, X.L.3
Bao, L.4
-
16
-
-
70350786394
-
Safety and immunogenicity of GMZ2-a MSP3-GLURP fusion protein malaria vaccine candidate
-
Esen M, et al. 2009. Safety and immunogenicity of GMZ2-a MSP3-GLURP fusion protein malaria vaccine candidate. Vaccine 27:6862-6868.
-
(2009)
Vaccine
, vol.27
, pp. 6862-6868
-
-
Esen, M.1
-
17
-
-
78650911621
-
Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice
-
Freches D, et al. 2011. Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice. Clin. Vaccine Immunol. 18:95-104.
-
(2011)
Clin. Vaccine Immunol.
, vol.18
, pp. 95-104
-
-
Freches, D.1
-
18
-
-
0030025636
-
Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG
-
Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. 1996. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect. Immun. 64:16-22. (Pubitemid 26009335)
-
(1996)
Infection and Immunity
, vol.64
, Issue.1
, pp. 16-22
-
-
Harboe, M.1
Oettinger, T.2
Wiker, H.G.3
Rosenkrands, I.4
Andersen, P.5
-
19
-
-
69449086810
-
Tolerance of the Ralstonia eutropha class I polyhydroxyalkanoate synthase for translational fusions to its C terminus reveals a new mode of functional display
-
Jahns AC, Rehm BHA. 2009. Tolerance of the Ralstonia eutropha class I polyhydroxyalkanoate synthase for translational fusions to its C terminus reveals a new mode of functional display. Appl. Environ. Microbiol. 75: 5461-5466.
-
(2009)
Appl. Environ. Microbiol.
, vol.75
, pp. 5461-5466
-
-
Jahns, A.C.1
Rehm, B.H.A.2
-
21
-
-
34248562792
-
+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge
-
DOI 10.1038/ni1449, PII NI1449
-
Khader SA, et al. 2007. IL-23 and IL-17 in the establishment of protective pulmonary CD4+T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369-377. (Pubitemid 46745412)
-
(2007)
Nature Immunology
, vol.8
, Issue.4
, pp. 369-377
-
-
Khader, S.A.1
Bell, G.K.2
Pearl, J.E.3
Fountain, J.J.4
Rangel-Moreno, J.5
Cilley, G.E.6
Shen, F.7
Eaton, S.M.8
Gaffen, S.L.9
Swain, S.L.10
Locksley, R.M.11
Haynes, L.12
Randall, T.D.13
Cooper, A.M.14
-
22
-
-
0027999182
-
T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy
-
Launois P, et al. 1994. T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect. Immun. 62:3679-3687.
-
(1994)
Infect. Immun.
, vol.62
, pp. 3679-3687
-
-
Launois, P.1
-
23
-
-
33749577271
-
Particulate systems as adjuvants and carriers for peptide and protein antigens
-
DOI 10.2174/156720106778559029
-
Liang MT, Davies NM, Blanchfield JT, Toth I. 2006. Particulate systems as adjuvants and carriers for peptide and protein antigens. Curr. Drug Deliv. 3:379-388. (Pubitemid 44534050)
-
(2006)
Current Drug Delivery
, vol.3
, Issue.4
, pp. 379-388
-
-
Liang, M.T.1
Davies, N.M.2
Blanchfield, J.T.3
Toth, I.4
-
25
-
-
79955084247
-
Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein
-
Lu J, et al. 2011. Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein. Clin. Dev. Immunol. 2011:617892.
-
(2011)
Clin. Dev. Immunol.
, vol.2011
, pp. 617892
-
-
Lu, J.1
-
26
-
-
14844346783
-
Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system
-
Majlessi L, et al. 2005. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. J. Immunol. 174:3570-3579. (Pubitemid 40354066)
-
(2005)
Journal of Immunology
, vol.174
, Issue.6
, pp. 3570-3579
-
-
Majlessi, L.1
Brodin, P.2
Brosch, R.3
Rojas, M.-J.4
Khun, H.5
Huerre, M.6
Cole, S.T.7
Leclerc, C.8
-
27
-
-
9144267735
-
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
-
DOI 10.1038/nm1128
-
McShane H, et al. 2004. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat. Med. 10:1240-1244. (Pubitemid 39540442)
-
(2004)
Nature Medicine
, vol.10
, Issue.11
, pp. 1240-1244
-
-
McShane, H.1
Pathan, A.A.2
Sander, C.R.3
Keating, S.M.4
Gilbert, S.C.5
Huygen, K.6
Fletcher, H.A.7
Hill, A.V.S.8
-
28
-
-
67650506682
-
Production of functionalized biopolyester granules by recombinant Lactococcus lactis
-
Mifune J, Grage K, Rehm BHA. 2009. Production of functionalized biopolyester granules by recombinant Lactococcus lactis. Appl. Environ. Microbiol. 75:4668-4675.
-
(2009)
Appl. Environ. Microbiol.
, vol.75
, pp. 4668-4675
-
-
Mifune, J.1
Grage, K.2
Rehm, B.H.A.3
-
29
-
-
34547624348
-
Poor correlation between BCG vaccinationinduced T cell responses and protection against tuberculosis
-
Mittrücker HW, et al. 2007. Poor correlation between BCG vaccinationinduced T cell responses and protection against tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 104:12434-12439.
-
(2007)
Proc. Natl. Acad. Sci. U. S. A.
, vol.104
, pp. 12434-12439
-
-
Mittrücker, H.W.1
-
30
-
-
35648958112
-
Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion
-
DOI 10.1159/000106082
-
Morello E, et al. 2008. Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion. J. Mol. Microbiol. Biotechnol. 14:48-58. (Pubitemid 350022332)
-
(2008)
Journal of Molecular Microbiology and Biotechnology
, vol.14
, Issue.1-3
, pp. 48-58
-
-
Morello, E.1
Bermudez-Humaran, L.G.2
Llull, D.3
Sole, V.4
Miraglio, N.5
Langella, P.6
Poquet, I.7
-
31
-
-
77951976478
-
Design of a single-chain multi-enzyme fusion protein establishing the polyhydroxybutyrate biosynthesis pathway
-
Mullaney JA, Rehm BHA. 2010. Design of a single-chain multi-enzyme fusion protein establishing the polyhydroxybutyrate biosynthesis pathway. J. Biotechnol. 147:31-36.
-
(2010)
J. Biotechnol.
, vol.147
, pp. 31-36
-
-
Mullaney, J.A.1
Rehm, B.H.A.2
-
32
-
-
0031783218
-
Ovalbumin peptide encapsulated in poly(d,l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response
-
DOI 10.1016/S0168-3659(97)00142-9, PII S0168365997001429
-
Newman KD, Samuel J, Kwon G. 1998. Ovalbumin peptide encapsulated in poly(D,L lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response. J. Control. Release 54:49-59. (Pubitemid 28255237)
-
(1998)
Journal of Controlled Release
, vol.54
, Issue.1
, pp. 49-59
-
-
Newman, K.D.1
Samuel, J.2
Kwon, G.3
-
33
-
-
34250794992
-
The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation
-
Ordway D, et al. 2007. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid downregulation. J. Immunol. 179:522-531. (Pubitemid 46986569)
-
(2007)
Journal of Immunology
, vol.179
, Issue.1
, pp. 522-531
-
-
Ordway, D.1
Henao-Tamayo, M.2
Harton, M.3
Palanisamy, G.4
Troudt, J.5
Shanley, C.6
Basaraba, R.J.7
Orme, I.M.8
-
34
-
-
79952404380
-
Development of new vaccines and drugs for TB: Limitations and potential strategic errors
-
Orme IM. 2011. Development of new vaccines and drugs for TB: Limitations and potential strategic errors. Future Microbiol. 6:161-177.
-
(2011)
Future Microbiol.
, vol.6
, pp. 161-177
-
-
Orme, I.M.1
-
36
-
-
83155188284
-
Production of a particulate hepatitis C vaccine candidate by engineered Lactococcus lactis
-
7 October posting date. doi:10.1128/AEM.06420-11
-
Parlane NA, et al. 7 October 2011, posting date. Production of a particulate hepatitis C vaccine candidate by engineered Lactococcus lactis. Appl. Environ. Microbiol. doi:10.1128/AEM.06420-11.
-
(2011)
Appl. Environ. Microbiol.
-
-
Parlane, N.A.1
-
37
-
-
73249118643
-
Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents
-
Parlane NA, Wedlock DN, Buddle BM, Rehm BHA. 2009. Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents. Appl. Environ. Microbiol. 75:7739-7744.
-
(2009)
Appl. Environ. Microbiol.
, vol.75
, pp. 7739-7744
-
-
Parlane, N.A.1
Wedlock, D.N.2
Buddle, B.M.3
Rehm, B.H.A.4
-
38
-
-
35448964302
-
The inherent property of polyhydroxyalkanoate synthase to form spherical PHA granules at the cell poles: The core region is required for polar localization
-
DOI 10.1016/j.jbiotec.2007.03.001, PII S0168165607001873, Biological Polyesters 2006
-
Peters V, Becher D, Rehm BH. 2007. The inherent property of polyhydroxyalkanoate synthase to form spherical PHA granules at the cell poles: the core region is required for polar localization. J. Biotechnol. 132:238-245. (Pubitemid 47632859)
-
(2007)
Journal of Biotechnology
, vol.132
, Issue.3
, pp. 238-245
-
-
Peters, V.1
Becher, D.2
Rehm, B.H.A.3
-
39
-
-
41549140412
-
Protein engineering of streptavidin for in vivo assembly of streptavidin beads
-
Peters V, Rehm BHA. 2008. Protein engineering of streptavidin for in vivo assembly of streptavidin beads. J. Biotechnol. 134:266-274.
-
(2008)
J. Biotechnol.
, vol.134
, pp. 266-274
-
-
Peters, V.1
Rehm, B.H.A.2
-
40
-
-
0030914026
-
Predominant recognition of the ESAT-6 protein in the first phase of infection with Mycobacterium bovis in cattle
-
Pollock JM, Andersen P. 1997. Predominant recognition of the ESAT-6 protein in the first phase of infection with Mycobacterium bovis in cattle. Infect. Immun. 65:2587-2592. (Pubitemid 27264082)
-
(1997)
Infection and Immunity
, vol.65
, Issue.7
, pp. 2587-2592
-
-
Pollock, J.M.1
Andersen, P.2
-
41
-
-
0033394970
-
Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis
-
DOI 10.1086/314640
-
Ravn P, et al. 1999. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J. Infect. Dis. 179:637-645. (Pubitemid 30016147)
-
(1999)
Journal of Infectious Diseases
, vol.179
, Issue.3
, pp. 637-645
-
-
Ravn, P.1
Demissie, A.2
Eguale, T.3
Wondwosson, H.4
Lein, D.5
Amoudy, H.A.6
Mustafa, A.S.7
Jensen, A.K.8
Holm, A.9
Rosenkrands, I.10
Oftung, F.11
Olobo, J.12
Von Reyn, F.13
Andersen, P.14
-
44
-
-
0004136246
-
-
2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
-
Sambrook J, Fritsch EF, Maniatis T. 1989.Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
-
(1989)
Molecular Cloning: A Laboratory Manual
-
-
Sambrook, J.1
Fritsch, E.F.2
Maniatis, T.3
-
45
-
-
33748798927
-
Particulate delivery systems for animal vaccines
-
DOI 10.1016/j.ymeth.2006.05.023, PII S1046202306001678
-
Scheerlinck JP, Greenwood DL. 2006. Particulate delivery systems for animal vaccines. Methods 40:118-124. (Pubitemid 44415503)
-
(2006)
Methods
, vol.40
, Issue.1
, pp. 118-124
-
-
Scheerlinck, J.-P.Y.1
Greenwood, D.L.V.2
-
46
-
-
58849160540
-
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
-
Sharp FA, et al. 2009. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc. Natl. Acad. Sci. U. S. A. 106:870-875.
-
(2009)
Proc. Natl. Acad. Sci. U. S. A.
, vol.106
, pp. 870-875
-
-
Sharp, F.A.1
-
47
-
-
35349027729
-
Nanoparticles and microparticles as vaccine-delivery systems
-
DOI 10.1586/14760584.6.5.797
-
Singh M, Chakrapani A, O'Hagan D. 2007. Nanoparticles and microparticles as vaccine-delivery systems. Expert Rev. Vaccines 6:797-808. (Pubitemid 47607854)
-
(2007)
Expert Review of Vaccines
, vol.6
, Issue.5
, pp. 797-808
-
-
Singh, M.1
Chakrapani, A.2
O'Hagan, D.3
-
48
-
-
0344406062
-
A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis
-
DOI 10.1046/j.1365-2567.2003.01589.x
-
Skinner MA, et al. 2003. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis. Immunology 108:548-555. (Pubitemid 36469693)
-
(2003)
Immunology
, vol.108
, Issue.4
, pp. 548-555
-
-
Skinner, M.A.1
Ramsay, A.J.2
Buchan, G.S.3
Keen, D.L.4
Ranasinghe, C.5
Slobbe, L.6
Collins, D.M.7
De Lisle, G.W.8
Buddle, B.M.9
-
49
-
-
49149114971
-
Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles
-
Soares AP, et al. 2008. Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J. Immunol. 180:3569-3577.
-
(2008)
J. Immunol.
, vol.180
, pp. 3569-3577
-
-
Soares, A.P.1
-
50
-
-
55549118890
-
Deceptive imprinting and immune refocusing in vaccine design
-
Tobin GJ, et al. 2008. Deceptive imprinting and immune refocusing in vaccine design. Vaccine 26:6189-6199.
-
(2008)
Vaccine
, vol.26
, pp. 6189-6199
-
-
Tobin, G.J.1
-
51
-
-
0035996448
-
Comparative affects of plasmid-encoded interleukin 12 and interleukin 18 on the protective efficacy of DNA vaccination against Mycobacterium tuberculosis
-
DOI 10.1046/j.1440-1711.2002.01087.x
-
Triccas JA, Sun L, Palendira U, Britton WJ. 2002. Comparative affects of plasmid-encoded interleukin 12 and interleukin 18 on the protective efficacy of DNA vaccination against Mycobacterium tuberculosis. Immunol. Cell Biol. 80:346-350. (Pubitemid 34779692)
-
(2002)
Immunology and Cell Biology
, vol.80
, Issue.4
, pp. 346-350
-
-
Triccas, J.A.1
Sun, L.2
Palendira, U.3
Britton, W.J.4
-
52
-
-
79851470191
-
Targeting diseases with genetically engineered Lactococcus lactis and its course towards medical translation
-
Villatoro-Hernandez J, Montes-De-Oca-Luna R, Kuipers OP. 2011. Targeting diseases with genetically engineered Lactococcus lactis and its course towards medical translation. Expert Opin. Biol. Ther. 11:261-267.
-
(2011)
Expert Opin. Biol. Ther.
, vol.11
, pp. 261-267
-
-
Villatoro-Hernandez, J.1
Montes-De-Oca-Luna, R.2
Kuipers, O.P.3
-
53
-
-
46249095305
-
Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone
-
DOI 10.1128/CVI.00034-08
-
Wedlock DN, et al. 2008. Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone. Clin. Vaccine Immunol. 15:765-772. (Pubitemid 351967029)
-
(2008)
Clinical and Vaccine Immunology
, vol.15
, Issue.5
, pp. 765-772
-
-
Wedlock, D.N.1
Denis, M.2
Painter, G.F.3
Ainge, G.D.4
Vordermeier, H.M.5
Hewinson, R.G.6
Buddle, B.M.7
-
54
-
-
21144465149
-
Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone
-
Wedlock DN, et al. 2005. Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone. Infect. Immun. 73:3540-3546.
-
(2005)
Infect. Immun.
, vol.73
, pp. 3540-3546
-
-
Wedlock, D.N.1
-
55
-
-
0032967705
-
PHA applications: Addressing the price performance issue I. Tissue engineering
-
DOI 10.1016/S0141-8130(99)00022-7, PII S0141813099000227
-
Williams SF, Martin DP, Horowitz DM, Peoples OP. 1999. PHA applications: addressing the price performance issue. I. Tissue engineering. Int. J. Biol. Macromol. 25:111-121. (Pubitemid 29301989)
-
(1999)
International Journal of Biological Macromolecules
, vol.25
, Issue.1-3
, pp. 111-121
-
-
Williams, S.F.1
Martin, D.P.2
Horowitz, D.M.3
Peoples, O.P.4
-
56
-
-
78651416505
-
Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination
-
Zhang Q, Zhong J, Huan L. 2011. Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination. Microbiol. Res. 166:111-120.
-
(2011)
Microbiol. Res.
, vol.166
, pp. 111-120
-
-
Zhang, Q.1
Zhong, J.2
Huan, L.3
|